Ticker name:SMMTSummit Therapeutics Inc.

Country: US-Sector: Healthcare, Industry: Biotechnology

Summit Therapeutics Inc. is a biopharmaceutical firm dedicated to discovering, developing, and commercializing therapeutic solutions, primarily targeting infectious diseases across the United States and Latin America. The company's clinical development pipeline is heavily concentrated on therapies for Clostridioides difficile infection (CDI). Its flagship product candidate, ridinilazole, is an orally administered small molecule antibiotic currently advancing through Phase III clinical trials as a treatment for CDI. Beyond its lead asset, Summit Therapeutics is also progressing SMT-738, designed to combat multidrug-resistant infections, notably carbapenem-resistant Enterobacteriaceae (CRE). Additionally, its DDS-04 series represents a potential therapeutic avenue for various infections caused by the Enterobacteriaceae family of bacteria. Established in 2003, the company maintains its headquarters in Cambridge, Massachusetts.

Market Cap 11B

Last close 13.66$

Key metrics

Largest 20 companies In Biotechnology

# PositionTickerCompany NameMarket CapLast PriceAction
1VRTXVERTEX PHARMACEUTICALS INC / MA121B477.36$
2REGNREGENERON PHARMACEUTICALS, INC.69B656.01$
3RVMDRevolution Medicines, Inc.40B189.23$
4ALNYALNYLAM PHARMACEUTICALS, INC.36B271.77$
5ROIVRoivant Sciences Ltd.25B35.01$
6INCYINCYTE CORP24B117.67$
7INSMINSMED Inc23B106.92$
8UTHRUNITED THERAPEUTICS Corp22B528.47$
9MRNAModerna, Inc.21B54.07$
10NBIXNEUROCRINE BIOSCIENCES INC18B175.77$
11BBIOBridgeBio Pharma, Inc.16B84.02$
12JAZZJazz Pharmaceuticals plc16B253.87$
13ASNDAscendis Pharma A/S16B253.86$
14EXELEXELIXIS, INC.14B55.37$
15MDGLMADRIGAL PHARMACEUTICALS, INC.13B544.51$
16AXSMAxsome Therapeutics, Inc.12B241$
17ARWRARROWHEAD PHARMACEUTICALS, INC.12B85.6$
18BMRNBIOMARIN PHARMACEUTICAL INC11B59.33$
19TECHBIO-TECHNE Corp11B71.6$
20SMMTSummit Therapeutics Inc.11B13.66$